These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28595838)

  • 1. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.
    Sistigu A; Di Modugno F; Manic G; Nisticò P
    Cytokine Growth Factor Rev; 2017 Aug; 36():67-77. PubMed ID: 28595838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fundamental role of mechanical properties in the progression of cancer disease and inflammation.
    Mierke CT
    Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
    Bocci F; Gearhart-Serna L; Boareto M; Ribeiro M; Ben-Jacob E; Devi GR; Levine H; Onuchic JN; Jolly MK
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):148-157. PubMed ID: 30587589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer cell plasticity: Impact on tumor progression and therapy response.
    da Silva-Diz V; Lorenzo-Sanz L; Bernat-Peguera A; Lopez-Cerda M; Muñoz P
    Semin Cancer Biol; 2018 Dec; 53():48-58. PubMed ID: 30130663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
    Chockley PJ; Keshamouni VG
    J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression.
    Tomecka P; Kunachowicz D; Górczyńska J; Gebuza M; Kuźnicki J; Skinderowicz K; Choromańska A
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.
    Razmkhah M; Abtahi S; Ghaderi A
    Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
    Patel S; Alam A; Pant R; Chattopadhyay S
    Front Immunol; 2019; 10():2872. PubMed ID: 31921137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.
    Ye J; Wu D; Wu P; Chen Z; Huang J
    Tumour Biol; 2014 May; 35(5):3945-51. PubMed ID: 24420150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
    Pietilä M; Ivaska J; Mani SA
    Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy.
    Baulida J; García de Herreros A
    Biochim Biophys Acta; 2015 Aug; 1856(1):55-61. PubMed ID: 26050961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and cancer stem cells.
    Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
    Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review.
    Wang S; Huang S; Sun YL
    Biomed Res Int; 2017; 2017():2646148. PubMed ID: 29379795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.